Fibrin sealant, aprotinin, and immune response in children undergoing operations for congenital heart disease

Bidstrup, 1989, Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin (Trasylol), J Thorac Cardiovasc Surg, 97, 364, 10.1016/S0022-5223(19)34573-8

Royston, 1992, High-dose aprotinin therapy: a review of the first five years' experience, J Cardiothorac Vasc Anesth, 6, 76, 10.1016/1053-0770(91)90052-U

Matras, 1978, Spinale Klebung mit Fibrinkleber, Wien Klin Wochenschr, 90, 419

1994

Spotnitz, 1995, Fibrin sealant in the United States: clinical use at the University of Virginia, Thromb Haemost, 74, 482, 10.1055/s-0038-1642725

Dietrich, 1997, Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations, J Thorac Cardiovasc Surg, 113, 194, 10.1016/S0022-5223(97)70415-X

Verstraete, 1985, Clinical application of inhibitors of fibrinolysis, Drugs, 29, 236, 10.2165/00003495-198529030-00003

Schulze, 1993, Severe anaphylactic shock due to repeated application of aprotinin in patients following intrathoracic aortic replacement, Eur J Cardiothorac Surg, 7, 495, 10.1016/1010-7940(93)90280-O

Diefenbach, 1995, Fatal anaphylactic shock after aprotinin reexposure in cardiac surgery, Anesth Analg, 80, 830

Martinelli, 1996, Aprotinin in staged heart transplantation: anaphylactic potential of repeated exposure, Ann Thorac Surg, 61, 1288, 10.1016/0003-4975(96)81293-8

Ishizaka, 1984, Activation of mast cells for mediator release through IgE receptors, 188

Colten, 1994, Immunology: drawing a double-edged sword, Nature, 371, 474, 10.1038/371474a0

Bergamaschini, 1996, Study of complement-mediated anaphylaxis in humans: the role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes, J Immunol, 156, 1256, 10.4049/jimmunol.156.3.1256

Yanagihara, 1985, Immunological studies on patients who received aprotinin therapy, Jpn J Allergy, 34, 899

Ruskowski, 1993, Untersuchungen zur Antigenitädat von Trasylol in der offenen Herzchirurgie, Thorac Cardiovasc Surg, 41suppl, 142

Pfannschmidt, 1995, Routine intraoperative application of high-dose aprotinin in open heart surgery in adults: antibody formation after first exposure, Curr Med Res Opin, 13, 282, 10.1185/03007999509111553

Dewachter, 1993, Anaphylactic reaction to aprotinin during cardiac surgery, Anaesthesia, 48, 1110, 10.1111/j.1365-2044.1993.tb07557.x

Kon, 1994, Anaphylactic reaction to aprotinin following topical use of biological tissue sealant, Masui, 43, 1606

Mitsuhata, 1994, An anaphylactic reaction to topical fibrin glue, Anesthesiology, 81, 1074, 10.1097/00000542-199410000-00034

Scheule, 1997, Anaphylactic shock after aprotinin reexposure: time course of aprotinin-specific antibodies, Ann Thorac Surg, 63, 242, 10.1016/S0003-4975(96)01062-4

Wüthrich, 1992, IgE-mediated anaphylactic reaction to aprotinin during anaesthesia, Lancet, 340, 173, 10.1016/0140-6736(92)93247-K

van der Zee, 1991, The role of IgG in immediate-type hypersensitivity, Eur Respir J, 4, 91s

Kleinert, 1983, Tod nach Bienenstich: Erstmaliger Nachweis eines IgG4-mediierten anaphylaktischen Schocks, Wien Klin Wochenschr, 95, 245

Kraft, 1976, Clinical patterns and results of radioallergosorbent test (RAST) and skin tests in penicillin allergy, Br J Dermatol, 94, 593, 10.1111/j.1365-2133.1976.tb05156.x

Laxenaire, 1993, Drugs and other agents involved in anaphylactic shock occurring during anaesthesia: a French multicenter epidemiological inquiry, Ann Fr Anesth Reanim, 12, 91, 10.1016/S0750-7658(05)81015-9

Rousou, 1989, Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations, J  Thorac Cardiovasc Surg, 97, 194, 10.1016/S0022-5223(19)35324-3

Borst, 1982, Clinical use of fibrin adhesive: summary, Thorac Cardiovasc Surg, 30, 241, 10.1055/s-2007-1022398